Location: Home > Pharma China Web Edition
  • search
  • go
  • Feature Articles
  • 2/20/2024Ozempic Is Taking Off With the World's Largest Obese Population (Hint:...
  • 2/19/2024AZ CEO: China Has Become Fundamental Part of Pharma Industry (Bloomber...
  • 2/16/2024As U.S.-China Biotech Tensions Rise, Korea Holds Its Breath (Korean Jo...
  • 2/16/2024Anti-China Biotech Policy: Biosecure & Beyond (BioCentury Video)
  • 2/8/2024Fresh Formulas for Growth: Assessing Asia in the New Year (PharmExec)
  • 2/6/2024Profit-flush China Pharma Firms Cast Eyes South (The Asset)
  • 2/6/2024Global Pharma Invests in China on the Strength of a Booming National B...
  • 2/5/2024Biotech Is the New Focus in U.S.-China Tech Rivalry (Axios)
  • 2/5/2024Number of Pharmacists in China in 2022, by Region (Statista)
  • 1/30/20242024 China Medtech Industry Outlook (Simon Kucher)
  • 1/23/2024Annual Per Capita Expenditure of Urban Households in China on Health C...
  • 1/22/2024Out-licensing Deals Between Chinese Pharma and Global Companies are He...
  • 1/18/2024China Biopharma Tracker 2023 (PharmaDJ)
  • 1/17/2024Assessing the Price Levels of Medical Service and Influential Factors:...
  • 1/14/2024JPM24: Roche's Pharma BD Chief Explains Renewed ADC Interest But Is Sp...
  • 1/10/2024Can China Halt the Exodus from Its State Health Insurance Scheme as En...
  • 1/9/2024Chinese Patent Examination Guidelines 2023 – Toby's Observations
  • 1/8/2024Foreign Drug Giants Shift Strategy on China Sales as Competition Ramps...
  • 1/7/2024Christmas Present from China – Implementation Regulations of the Chin...
  • 1/7/2024Why Is TikTok Parent ByteDance Moving into Biology, Chemistry and Drug...
  • 1/7/2024Chinese Pharmaceutical Companies Chart New Paths in the Middle East (K...
  • 1/6/2024Balancing Medical Innovation and Affordability in The New Healthcare E...
  • 12/28/2023China's Revised Measures for the Administration and Registration of Fo...
  • 12/27/2023Why AstraZeneca's Gracell Biotechnologies Acquisition Is A Win-Win (Se...
  • 12/26/20232024 Forecast: Big Pharma Reworks China Strategy, And Job Cuts Are Par...
  • 12/20/2023China NRDL 2023 Readout: the Seven-year Itch (Simon Kucher)
  • 12/15/2023China Biopharma Tracker – Novermber 2023 (PharmaDJ)
  • 12/14/2023The Impact of Experimental Data on Support of Disclosure and Inventive...
  • 12/12/2023Can China's Biotech Industry Weather Frosty US Relations? (PharmaPhoru...
  • 12/6/2023Asia Toughing Out the Uncertainties and Challenges (BioSpectrum)
  • Page:4/7 Total number of articles:186: [First][<<] [2] [3] [4] [5] [6] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group